SCHEMBL8766672

SCHEMBL8766672

CCOP(=O)(CN(c1ccc(OC)cc1)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 3/20 0.43
NR1I2 O75469 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
LMNA P02545 2/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 2/20 0.34
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALOX5 P09917 1/20 0.33
MTNR1A P48039 2/20 0.32
MTNR1B P49286 2/20 0.32
MAPT P10636 2/20 0.32
EGFR P00533 1/20 0.32
MAOA P21397 1/20 0.32
ACHE P22303 1/20 0.32
MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766583 0.91 HMGCR (0.43) HMGCRNR1I2CA1CA2LMNA
SCHEMBL8766983 0.89 HMGCR (0.45) HMGCRNR1I2CA1CA2LMNA
SCHEMBL8766044 0.87 HMGCR (0.43) HMGCRNR1I2CA1CA2LMNA
SCHEMBL8766643 0.87 HMGCR (0.48) HMGCRNR1I2LMNARECQLKMT2A
SCHEMBL8766637 0.85 CA1 (0.46) HMGCRNR1I2CA1CA2LMNA
SCHEMBL8609257 0.85 HMGCR (0.43) HMGCRNR1I2CA1CA2LMNA
SCHEMBL8766474 0.82 HMGCR (0.42) HMGCRNR1I2LMNARECQLCYP3A4
SCHEMBL8767341 0.81 HMGCR (0.43) HMGCRNR1I2LMNARECQLKMT2A
SCHEMBL8766713 0.81 HMGCR (0.44) HMGCRNR1I2CA2LMNARECQL
SCHEMBL7120195 0.79 HMGCR (0.43) HMGCRNR1I2LMNARECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP claimed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP disclosed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US disclosed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP disclosed